ABLYNX AWARDED EU2.1 MILLION GRANT TO SUPPORT DEVELOPMENT

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
ABLYNX AWARDED EU2.1 MILLION GRANT TO SUPPORT DEVELOPMENT OF NOVEL NANOBODIES(R) FOR OCULAR APPLICATIONS

GHENT, Belgium, Aug. 13, 2014 (GLOBE NEWSWIRE) -- Ablynx [Euronext Brussels: ABLX] today announced that it has been awarded a €2.1 million grant by the Flemish Agency for Innovation by Science and Technology (IWT) to help advance a wholly-owned programme, which will explore a novel approach to the treatment of diseases of the eye by utilising some of the unique characteristics of Nanobodies. The grant is available over a period of three years and will allow the development and subsequent testing of Nanobody leads in relevant pre-clinical disease models. 

Dr Tony De Fougerolles, CSO of Ablynx, commented: "This grant is a further clear endorsement of the innovative potential of the Nanobody platform and its ability to generate differentiated drugs in disease areas which are scientifically challenging and which represent a high unmet medical need. Ophthalmology is an increasingly important area for many pharmaceutical companies as they seek to meet the demands of an ageing population. We are very grateful for the continued commitment by IWT to support world-class science in Belgium."             

About Ablynx

Ablynx is a biopharmaceutical company engaged in the discovery and development of Nanobodies® , a novel class of therapeutic proteins based on single-domain antibody fragments, for a range of serious human diseases, including inflammation, haematology, oncology and pulmonary disease. Today, the Company has more than 30 programmes in the pipeline and seven Nanobodies in clinical development. Ablynx has on-going research collaborations and significant partnerships with major pharmaceutical companies including AbbVie, Boehringer Ingelheim, Merck & Co, Merck Serono and Novartis. The Company is headquartered in Ghent, Belgium. More information can be found on www.ablynx.com .

For more information, please contact

Ablynx:

Dr Edwin Moses
CEO
t:   +32 (0)9 262 00 07
m: +44 (0)7771 954 193 /
     +32 (0)473 39 50 68
e:  edwin.moses@ablynx.com

Marieke Vermeersch
Associate Director Investor Relations
t:   +32 (0)9 262 00 82
m: +32 (0)479 49 06 03
e:  marieke.vermeersch@ablynx.com
Follow us on Twitter @AblynxABLX

Ablynx media relations Consilium Strategic Communications:

Mary-Jane Elliott, Amber Bielecka, Lindsey Neville
t:   +44 203 709 5700
e:  ablynx@consilium-comms.com

Pdf version of the press release http://hugin.info/137912/R/1848300/644939.pdf

HUG#1848300

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 9

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 9

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 13

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 12

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 13

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 8

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 11

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 7

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
C3EL Expands Federal Footprint with Strategic Contracts

Updated Category News Views 5

Pushing Boundaries in Federal Contracts What a ride C3EL's had in Government Fiscal Year 2026! Let me tell you, they’ve bagged a bunch of contracts that’d make any company’s mouth water. Kicking things off, they snagged a prime cybersecurity contract from the U.S. Air Force. Considering our current cybersecurity landscape, that's like striking gold. But they...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 7

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading

Top 5 Most Recently Viewed Articles

Conavi Medical Highlights Growth Potential and Financial Updates

Updated Category News Views 110

Conavi Medical's Financial Progress and Strategic Updates Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) has recently completed an impressive upsized financing of $20 million. This funding, primarily driven by U.S. institutional investors, is anticipated to play a crucial role in advancing the company towards the commercial launch of its next-generation Novasight...

Continue Reading
Understanding the Recent Dealing Disclosure by Treatt plc

Updated Category News Views 170

Recent Dealings by Treatt plc and Their Implications Treatt plc has recently come under the spotlight due to its activities in share dealing, marked by a valuable update that reflects the company's engagement in the financial markets. These disclosures are not just formalities; they provide investors with insights into the ongoing operational dynamics of the company and...

Continue Reading
Ellomay Capital's Growth in Italian Solar Energy Initiatives

Updated Category News Views 130

Ellomay Capital's Expansion in Italian Solar Energy Ellomay Capital Ltd. (NYSE American; TASE: ELLO), a prominent player in the renewable energy sector, has made significant strides with its solar projects in Italy. The company recently announced the achievement of a critical milestone with the successful award of the FER X Tender for its 79.5 MW solar project, "Ellomay...

Continue Reading
AIME Marks Successful Seventh Annual Fuse National Conference

Updated Category News Views 162

AIME Celebrates Success at the Seventh Annual Fuse National Conference Recently, the Association of Independent Mortgage Experts (AIME) marked an important milestone with its seventh annual Fuse National Conference, which took place in lively New Orleans, moving away from its traditional Las Vegas location for the first time. In spite of recent hurdles, including...

Continue Reading
Finnovate Acquisition Corp. Updates Monthly Sponsor Contributions

Updated Category News Views 75

Finnovate Acquisition Corp. Updates on Sponsor Contributions Finnovate Acquisition Corp. (Nasdaq: FNVT, FNVTU, FNVTW) has made an important announcement regarding its upcoming extraordinary general meeting of shareholders. The company is proposing an extension of time to facilitate its initial business combination. In light of this, the Finnovate Sponsor, L.P. is revising...

Continue Reading